Clinical and radiological features of extra-pulmonary sarcoidosis: a pictorial essay by Stefano Palmucci et al.
PICTORIAL REVIEW
Clinical and radiological features of extra-pulmonary sarcoidosis:
a pictorial essay
Stefano Palmucci1 & Sebastiano Emanuele Torrisi2 & Daniele Carmelo Caltabiano1 &
Silvia Puglisi2 & Viviana Lentini3 & Emanuele Grassedonio4 & Virginia Vindigni2 &
Ester Reggio5 & Riccardo Giuliano2 & Giuseppe Micali6 & Rosario Caltabiano7 &
Cosma Andreula8 & Pietro Valerio Foti1 & Giovanni Carlo Ettorre1 & Simon LF Walsh9 &
Carlo Vancheri2
Received: 30 December 2015 /Revised: 7 April 2016 /Accepted: 22 April 2016 /Published online: 25 May 2016
# The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract
The aim of this manuscript is to describe radiological find-
ings of extra-pulmonary sarcoidosis. Sarcoidosis is an
immune-mediated systemic disease of unknown origin,
characterized by non-caseating epitheliod granulomas.
Ninety percent of patients show granulomas located in
the lungs or in the related lymph nodes. However, lesions
can affect any organ. Typical imaging features of liver and
spleen sarcoidosis include visceromegaly, with multiple
nodules hypodense on CT images and hypointense on
T2-weighted MRI acquisitions. Main clinical and radiolog-
ical manifestations of renal sarcoidosis are nephrolithiasis,
nephrocalcinosis, and acute interstitial nephritis. Brain sar-
coidosis shows multiple or solitary parenchymal nodules
on MRI that enhance with a ring-like appearance after gad-
olinium. In spinal cord localization, MRI demonstrates en-
largement and hyperintensity of spinal cord, with
hypointense lesions on T2-weighted images. Skeletal in-
volvement is mostly located in small bone, showing many
lytic lesions; less frequently, bone lesions have a sclerotic
appearance. Ocular involvement includes uveitis, conjunc-
tivitis, optical nerve disease, chorioretinis. Erythema
nodosum and lupus pernio represent the most common
cutaneous manifestations encountered. Sarcoidosis in var-
ious organs can be very insidious for radiologists, showing
different imaging features, often non-specific. Awareness
of these imaging features helps radiologists to obtain the
correct diagnosis.
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Teaching Points
• Systemic sarcoidosis can exhibit abdominal, neural, skeletal,
ocular, and cutaneous manifestations.
• T2 signal intensity of hepatosplenic nodules may reflect the
disease activity.
• Heerfordt’s syndrome includes facial nerve palsy, fever, pa-
rotid swelling, and uveitis.
• In the vertebrae, osteolytic and/or diffuse sclerotic lesions
can be found.
• Erythema nodosum and lupus pernio represent the most
common cutaneous manifestations.
Keywords Sarcoidosis . Granulomatous disease, chronic .
Multidetector computed tomography .Magnetic resonance
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Introduction
Sarcoidosis is a multi-systemic disorder of unknown cause,
pathologically characterized by the accumulation of inflam-
matory cells forming non-caseating granulomas. Lesions can
be located in any organ but in about 90 % of patients, granu-
lomas affect the lungs or the related lymph nodes [1].
According to Geize et al., sarcoidosis can be encountered in
extra-pulmonary locations, in approximately 30 % of cases
[2]. Moreover, the study entitled BA Case Control Etiologic
Study of Sarcoidosis^ (ACCESS) provided an accurate anal-
ysis regarding distribution of the disease: in 736 sarcoidosis
cases, 699 patients showed thoracic disease, and 368 out of the
736 patients had concomitant extra-thoracic disease [3–5];
isolated extra-pulmonary disease was found only in a small
percentage of cases (2 %) [3, 5].
The systemic location of the disease can be very insidious
for radiologists: a wide variety of imaging features are found,
often non-specific, which can mimic other pathological con-
ditions [6, 7]. Therefore, the aim of this pictorial essay is to
describe the most important clinical features and the main
radiological findings of sarcoidosis in various organs, in order
to help radiologists in the identification of the disease.
Epidemiology
The disease affects young men and women aged between 25
and 40 years, without major differences in ethnicity. Some stud-
ies do show a greater incidence in females [8]. In about 30 % of
cases, there is a second peak incidence from 50 to 65 years of
age. This second peak mostly affects women showing clinical
characteristics that differ from those of younger patients [9, 10].
The annual incidence varies widely from country to country. In
northern Europe it is about 5-40/100,000, which represents the
highest value reported; in Japan the incidence is lower, with a
value of about 1-2/100,000. Afro-Americans are the most af-
fected (35.5/100,000), whereas white Americans have an inci-
dence of 10.9/100,000 [8].
Normally, sarcoidosis shows a variable clinical course; it
may also exhibit different extra-thoracicmanifestations. These
vary widely according to ethnicity: for example, involvement
of the eye, liver, bone marrow, extra-thoracic lymph nodes,
and skin has been more statistically associated with African
Americans than with Caucasians [3, 5].
Cardiac and ocular diseases are frequently encountered in
Japanese patients, erythema nodosum in northern Europeans,
and ocular and granulomatous skin involvement in black pa-
tients [11–13]. In addition, regarding cutaneous lesions, Lupus
pernio has been frequently observed in Puerto Ricans.
Extra-thoracic sarcoidosis involves females more frequent-
ly than males [3].
Extra-pulmonary sarcoidosis: clinical and imaging
features
Extra-pulmonary sarcoidosis has been found in 30 % of pa-
tients with the disease [2]. The most common site reported in
the paper by Gezer et al. is the abdomen, which includes liver,
spleen, biliary tree, peritoneum, and lymphatic sarcoidosis [2].
The cutaneous system and the eyes are involved with a
frequency of 25 % [14, 15]. Following data reported in the
paper by Rao et al., the third most affected organ is the eye,
with a frequency of involvement ranging from 10 to 60 %
[11]. However, according to data reported by Koyama et al.,
ocular sarcoidosis is found with higher frequency, being about
80 % [16]. Skin lesions are found in 20 to 35 % of patients
with sarcoidosis [11, 17, 18]; similarly, a frequency of 25 %
for cutaneous involvement has been reported in other papers
[16, 19].
The following sections below describe more in detail
clinical and radiological features of systemic sarcoidosis
(Table 1), focusing on abdominal, neural, musculo-skeletal,
cutaneous, ocular, and cardiac manifestations.
Abdominal sarcoidosis
Hepatic sarcoidosis
Hepatic sarcoidosis occurs with a prevalence of 1-40/100,000;
it generally involves young people [20]. The disease is
underestimated: indeed, involvement of hepatic parenchyma
is encountered—in autopsy specimens—in 50–80 % of cases
[16]. In 2–60 % of patients, laboratory tests show abnormal
levels, indicating an organ dysfunction [21]. Portal hyperten-
sion, cirrhosis and chronic cholestatic disease are rarely re-
ported from patients with hepatic sarcoidosis [22].
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Commonly, imaging demonstrates hepatomegaly, with ho-
mogeneous appearance of parenchyma [16]; very often, this
radiological feature is associated with splenomegaly and en-
largement of abdominal lymph nodes [20], which are encoun-
tered close to the liver hilus or in celiacal region. However, in
5–15% of cases, multiple nodular granulomas, ranging from 1
to 2 mm to several centimeters in diameter, become visible on
CT and MRI [16]. Nodular involvement—according to
Karagiannidis et al.—can be detected in low percentage
(<5 % of cases) [20].
Granulomatous lesions are located in the portal and
periportal spaces of hepatic sinuses and generally exhibit Ban
identical stage of maturation^ [20, 23]. They may be seen as
round or oval shaped hypoechoic nodules at ultrasound
(Fig. 1), involving hepatic parenchyma in a diffuse or limited
form. These nodules are hypodense on CT images and show a
low signal on MRI scan, especially in T2-weighted fat-saturat-
ed acquisitions. The nodules are generally hypointense on
gadolinium-enhanced T1-weighted acquisitions [23–25].
However, signal intensity depicted on T2-weighted images re-
flects the degree of activity of disease: nodules can appear
hyperintense in case of inflammation, due to oedema and high
vascular permeability (Fig. 2) [26]. Similarly, on diffusion
weighted imaging (DWI) acquisition, nodules with inflamma-
tion appear as high signal intensity lesions, with restriction on
apparent diffusion coefficient (ADC) map. Fibrotic nodules
show low signal on T2-weighted and diffusion sequences [26].
Splenic sarcoidosis
Splenic sarcoidosis is generally associated with lung disease;
however, normal chest radiography is observed in one quarter
Table 1 Main clinical and radiological features of sarcoidosis in different organs
Location Clinical features Imaging findings
Liver Hepatomegalia, enlargement of abdominal
lymph nodes
Round or oval shaped hypoechoic nodules at ultrasonography;
Hypodense nodules on CT images; Hypointense nodules on
T2-weighted MRI sequences and on gadolinium-enhanced
T1-weighted MRI acquisitions
Spleen Patients can be asymptomatic or complain
of fever, weight loss, and malaise
Ultrasound reveals splenomegaly with small hypoechoic nodules;
Hypodense nodules after contrast-enhanced CT images; Nodular
lesions with low signal in all sequences and visible in the early
gadolinium-enhanced T1 images
Gastro-intestinal Tract Disease involves gastric antrum, biliary
tree, and parotid glands
Small ulcerations of gastrointestinal tract; Enlargement of parotid
glands can be observed, with inhomogeneous or nodular pattern on
enhanced CT images; Increased T2-signal intensity on MRI
acquisitions of parotid glands
Lymphatic System Lymphadenopathy or increased number of
normal sized nodes
Enlarged nodes can be located in the periportal or para-aortocaval
region, close to the liver hilus, adjacent to the celiac trunk or
pancreas
Peritoneum Ascites and multiple nodules Hypoattenuating nodules on CT images, fluid accumulation in the
abdomen
Kidneys Nephrolithiasis, nephrocalcinosis,
nephrogenic diabetes insipidus, renal
insufficiency, acute interstitial nephritis
BStriated nephrogram^ can be found on CT and MRI acquisitions;
Granulomatous pseudotumor appears as hypo-/iso-/
hyperatteanuating area on unenhanced CT scans, hypodense after
contrast administration; Granulomatous pseudotumor shows low
signal on early and delayed images after gadolinium administration
Central Nervous System Signs of cranial nerve involvement;
headache, seizure, meningeal irritation
Lesions are hyperintense on T2-weighted MRI images, located in the
white and grey matter; Leptomeningeal localizations are more
visible after contrast injection, showing increased signal on
enhanced T1 acquisitions
Bone Hands and feet are the most common
locations
On conventional radiography, lesions produce a lacy pattern of
osteolytic areas in the digits; Large bone and axial skeleton lesions
can be detected as radiolucent or sclerotic areas
Heart Conduction disturbances and arrhythmias,
pericarditis
Granulomatous lesions are observed as areas of focal enhancement on
cardiac MRI, most frequently located in myocardial wall or
subepicardial region
Skeletal Sarcoidosis Involves hand and feet; large bones and
axial skeleton involvement is uncommon
Sclerotic areas consisting of hyperdense homogeneous areas, round or
oval in shape; osteolysis produces a hypodense appearance
Lesions with high signal intensity on T2-weighted images, high-
density proton sequences and STIR acquisitions; on T1-weighted
images, lesions are generally hypointense
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to one third of patients with splenic sarcoidosis [27]. Splenic
involvement has been reported in a variable percentage, rang-
ing from 24 to 59 % of biopsies [28–30]; at autopsy, the
frequency of sarcoid lesions in the splenic parenchyma is
about 41 % [31].
Patients can be asymptomatic, or complain of fever, weight
loss, and malaise [21, 32]. In the series reported byWarshauer
et al., splenomegaly has been found in one third of cases [32].
Hepatic and splenic contemporary involvement has been re-
ported in 5–15 % of cases [32].
Splenic sarcoidosis can be present in a homogeneous
fashion or in a nodular pattern [2, 27, 33]. At ultrasound,
splenic lesions may be detected as small nodules, with
hypoechoic attenuation in comparison to surrounding paren-
chyma. On CT images, lesions are generally revealed as
small hypodense nodules after contrast administration
(Fig. 3); nodules can be larger than 1 cm in size, with a
tendency to confluence (Fig. 4).
On MRI acquisitions, nodular lesions show low signal in
all sequences [34]; the visualization reaches an optimal level
on T2-weighted acquisition with fat suppression and in the
early gadolinium-enhanced T1 images (Fig. 5) [34, 35]. It
has recently pointed out that MRI is able to monitor the activ-
ity of the disease. On T2-weighted images, nodules can appear
hyperintense in cases of inflammation due to oedema and high
vascular permeability; also, on DWI acquisitions, inflamma-
tion of nodules show high signal intensity, with restriction on
ADC map [26].
Parenchymal lesions show increased FDG uptake on PET-
CT [36]: low-density areas on CT reveals multiple foci of
increased metabolic activity on PET images (Fig. 6).
Gastrointestinal sarcoidosis
Among abdominal sarcoidosis, autopsy revealed only a small
percentage of cases (5 %) located in pancreatic tissue,
Fig. 1 A 61-year-old female
patient affected by pulmonary
sarcoidosis, proved by biopsy.
Routine abdominal ultrasound
exam (on Fig. 1a and b) shows
multiple, small, randomly
distributed, hypoechoic nodules
in the liver parenchyma. Nodules






(white arrows) on T2-weighted
images (Fig. 2a and b) and on
diffusion weighted imaging
(DWI) (Fig. 2c and d); after
gadolinium administration,
nodules appear hypointense
(Fig. 2e and f). In hepato-splenic
sarcoidosis, T2 signal intensity
reflects the degree of activity of
disease: nodules can appear
hyperintense in case of
inflammation due to oedema and
high vascular permeability; they
have hypointense signal, when
fibrosis is prevalent (see curved
arrows for nodular lesions of the
spleen)
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intestinal tract, and testes [21]. The gastric antrum is the area
most frequently involved [11]. Along the gastrointestinal tract,
small ulcerations and mucosal thickening can be observed.
The biliary tree may be involved in extra-hepatic or intra-
hepatic pattern. Granulomatous lesions develop in the portal
triad, causing a cholestatic pattern.
Extra-hepatic involvement of the biliary tree can be caused
by multiple small granuloma of the wall; the radiological ap-
pearance in these cases may simulate a cholangiocarcinoma;
in many cases, the biliary tree may be compressed by enlarged
abdominal nodes.
According to Koyama et al., in 6 % of cases parotid glands
may have sarcoidosis involvement; generally, the disease is
found bilaterally, with enlargement of glands [16]. An inho-
mogeneous pattern can be observed on enhanced CT images
(Fig. 7); increased T2-signal intensity and nodular lesions are
observed on MRI acquisitions (Fig. 8). Increased uptake of
Gallium-67 reproduces the typical BPanda^ sign, even if this
radionuclide accumulation is also described in other patholog-
ical entities (lymphoma and HIV infection) [36].
Lymphatic and peritoneal sarcoidosis
Lymphatic abnormalities have been already described as ab-
dominal manifestations of sarcoidosis, consisting of
Blymphadenopathy or increased number of normal sized
nodes^ [37]; lymph nodes are generally 1–2 cm in size. In a
previous experience, abdominal adenopathy was reported in
approximately 30 % of patients; in these case series,
adenopathy was defined as Btwo or more nodes with a short
axis diameter greater than 6 mm^ [21].
Enlarged nodes can be observed in different locations: in
the periportal region, close to the liver hilus (Fig. 9), or be-
tween portal vein and vena cava. They can be found adjacent
to the celiac trunk or pancreas (Fig. 10), or in a paraaortic
disposition. Lymph nodes are also found around iliac vessels,
or in the mesentery. A diffuse abdominal nodes involvement
can be observed (Fig. 11). Necrosis or calcifications are rare in
sarcoidosis [21].
Lymphatic involvement is frequently associated with pul-
monary disease, and this can be very helpful for radiologists in
order to achieve a correct diagnosis. When the disease is lim-
ited to the lymphatic system in mediastinum and in the abdo-
men, a differential diagnosis from other disorders, e.g. lym-
phoma, may be very difficult.
Peritoneal sarcoidosis is extremely rare [2, 38–41]. It can
appear with ascites and multiple nodules: these imaging fea-
tures—as reported by Gezer et al.—should be differentiated
from other pathological conditions, which include carcinoma-
tosis, tuberculosis, and fungal infections [2].
Renal sarcoidosis
In sarcoidosis, the real incidence and prevalence of renal in-
volvement is difficult to establish, because the disease can
occur in a variable manner; in most cases, it has been found
in 35 to 50% of patients [42]. Main clinical manifestations are
nephrolithiasis, nephrocalcinosis, nephrogenic diabetes
insipidus, renal insufficiency, and acute interstitial nephritis
with or without granuloma; however, many patients with renal
involvement are asymptomatic.
Fig. 3 A 40-year-old female patient affected by pulmonary and splenic
sarcoidosis. Figure 3a shows splenic sarcoidosis in a nodular pattern; the
nodules (black arrowheads) are revealed as small hypodense nodules on
contrast-enhanced CT images. Ill-defined pulmonary opacities, with
small nodules around, are also depicted on Fig. 3b, resembling the typical
sarcoid galaxy sign (white arrow)
Fig. 4 Splenic sarcoidosis in a
58-year-old female. Splenic
parenchyma, on Fig. 4a, appears
slightly inhomogeneous. After
contrast administration (Fig. 4b
and c), large nodules (exceeding
1 cm) with hypodense appearance
are clearly depicted
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The increased levels of 1,25-dihydroxyvitamin, produced
by mononuclear cells trapped in pulmonary alveoli, deter-
mines a greater absorption of calcium: this leads to hypercal-
cemia and consequential nephrolithiasis and nephrocalcinosis
[43].
The prevalence of interstitial nephritis in sarcoidosis oscil-
lates from 7 to 27 % [44, 45]. The renal involvement may be
with or without granuloma. Granuloma interstitial nephritis is
the typical histological finding and is defined Bnaked with no
cuff of inflammatory cells with presence of asteroid bodies
and calcification^ [46]. This lesion differs form tuberculosis
granuloma for the absence of necrosis.
Enhanced CT images may show signs of interstitial nephri-
tis [21, 47, 48] with the typical Bstriated nephrogram^ repre-
sented by ill-defined hypodense lines into the renal parenchy-
ma. Diffusion MRI sequences show interstitial nephritis as
hyperintense areas, with signal restriction on apparent diffu-
sion coefficient map.
Rarely, radiological features of renal sarcoidosis can be
represented by granulomatous pseudotumour; these lesions
are generally incidentally discovered during CT examination.
They can appear as hypo-, iso-, or hypeattanuating areas on
unenhanced CT scans; after contrast administration, they are
hypodense to the surrounding renal parenchyma (Fig. 12)
Fig. 5 MRI appearance of a
splenic sarcoidosis (same patient
as Fig. 2). The visualization of the
nodules reaches an optimal level
on T2-weighted acquisition with
fat suppression (Fig. 5a) and in
the early gadolinium-enhanced
T1 images (Fig. 5b)
Fig. 6 FDG uptake on PET-CT
in a 57-year-old woman affected
by pulmonary and splenic
sarcoidosis. Increased metabolic
activity is appreciable in the left
pulmonary hilum, due to
pathological lymph nodes
(white arrowheads on Fig. 6a–b).
Similarly, splenic foci of
increased metabolic activity are
clearly seen on axial CT-PET
acquisitions (empty white
arrowheads respectively on
Fig. 6c–d), and on coronal and
sagittal reformatted images
(white arrows in Fig. 6e–h)
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[48]. Differential diagnosis includes lymphoma or other tu-
mours. On MRI acquisition, lesions show heterogeneous sig-
nal on unenhanced sequences and appear hypointense on early
and delayed images acquired after gadolinium administration
[48].
The urinary manifestations of sarcoid nephritis are nonspe-
cific: the alterations of the urine analysis are similar to those of
chronic tubular pathologies. Biopsy is the only way to make a
diagnosis, showing normal glomeruli with interstitial infiltra-
tion of mononuclear cells and non-caseating granulomas; oc-
casionally, it may be also depicted with glomerular disease
[49, 50].
Neurosarcoidosis
Central nervous system (CNS) involvement is reported in
25 % of cases at autopsy; in a post-mortem series, neural
sarcoidosis was detected with a frequency of 14–27 %
[51–54]. Symptoms due to neurosarcoidosis are not frequently
observed, being encountered in less than 10% of patients [16].
The disease shows a special predilection for the basal cis-
terna of the brain; cranial nerve involvement is frequent,
influencing the clinical manifestation of disease. Facial nerve
palsy, for example, is a typical manifestation of brain sarcoid-
osis in young adults [16]. It may be associated with chronic
fever, swelling of parotid gland and uveitis, configuring the
typical BHeerfordt’s syndrome^ (Fig. 13).
Other symptoms associated with neural sarcoidosis are
headache, seizure, and signs of meningeal irritation [55, 56].
Involvement of optical nerve leads to loss of vision, with a
poor prognosis [57].
Diagnosis of sarcoidosis can be performed following the
criteria reported in the study by Pawate et al., in which the
presence of neurosarcoidosis is evaluated as definite, proba-
ble, and possible. According to their criteria [57], the disease
is graded as Bdefinite^ when detected on histological speci-
mens. It is labelled as Bprobable^ when: a) laboratory tests are
positive for CNS inflammation (elevated levels of cerebrospi-
nal fluid protein or MRI features compatible with
neurosarcoidosis) b) detection of systemic sarcoidosis (posi-
tive histology and/or least two indirect indicators from gallium
scan, chest imaging and serum angiotensin-converting en-
zyme); the disease is considered possible when previous
criteria are not satisfied [57].
Lesions appear hyperintense on T2-weighted MRI images,
located in the superficial and deep white matter; sometimes,
these imaging features may resemble lesions of multiple scle-
rosis [58]. Also grey matter lesions are generally hyperintense
on T2-weighted sequences. In the series reported by Pawate et
al., contrast-enhancing parenchymal white matter lesions were
found in 10 out of 54 cases (19 %) [57].




pattern (white arrowheads), with
multiple and punctuate small
hypodense lesions. Figure 7c
show typical pattern of thoracic
disease on CT acquisitions
Fig. 8 Parotid sarcoidosis
(histologically proven), with
enlargement of glands (white
arrows). Nodular lesion is clearly
depicted in the parenchyma of left
parotid (white arrowheads in
Fig. 8a and b)
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Dural thickening is generally isointense to the grey matter
on T1-weighted acquisitions, hypointense on T2-weighted se-
quences, with contrast enhancement after gadolinium injec-
tion [59].
Leptomeningeal localizations are more visible after
contrast injection, showing increased enhancement
(Fig. 14) [58]. As reported by Urih et al., and subsequent-
ly by Christoforidis et al. [59], leptomeningeal infiltration
involves frequently the suprasellar and frontal basal
meninges.
Nodules can be solitary or multiple, showing enhance-
ment after contrast injection with a ring-like appearance in
the activity phase: this appearance can simulate glioblasto-
ma or metastases. An intracranial mass presentation has
been also reported in the literature, simulating a brain neo-
plasm [57].
Spinal sarcoidosis is reported in about 4–28 % of cases; it
occurs predominantly in old people and has a poor prognosis
[60]. The disease may be intramedullary or extramedullary.
Junger et al. distinguish four stages of disease: 1)
leptomeningeal enhancement; 2) fusiform spinal cord enlarge-
ment; 3) focal or diffuse intramedullary disease; 4) spinal cord
atrophy [61].
MRI features of stage 1 and 2 disease include
leptomeningeal thickening, with hyperintense signal on en-
hanced T1-weigheted images [60]. In cervical and thoracic
regions, intramedullary lesions appear hypointense in T2-
weightedMRI sequences with hyperintensity of the associated
oedema; they show enhancement (Fig. 15) on T1-weighted
images after contrast injection [58].
Skeletal sarcoidosis
The skeletal system represents a rare localization of sarcoido-
sis [62]. Radiological features of skeletal locations have been
described for the first time in 1910 by Rieder [62, 63]. It
occurs in a variable range of percentages, from 9 % up to
Fig. 9 A 66-year-old female
patient affected by sarcoidosis,




image (Fig. 9a) demonstrate
enlarged lymph nodes (white
arrows), located in perihepatic
region and close to the liver hilus;
inside these lymph nodes, very
small calcifications are
recognizable (black arrowheads).
Chest CT-scan shows mediastinal
lymphadenopathy, with some
punctate calcifications (white
arrowhead on Fig. 9b). After
contrast administration, both CT
and MRI acquisitions show
inhomogeneous enhancement of
enlarged lymph nodes (white
arrowheads on Fig. 9c and d)
Fig. 10 Incidental sarcoidosis diagnosis in a 59-year-old woman
complaining of acute abdominal pain. Unenhanced CT scan shows a
gallbladder calculus (white arrow on Fig. 10a) and some peri-pancreatic
lymph nodes (white arrowheads on Fig. 10b); then CT scan extended
through the chest (Fig. 10c) showed multiple, small subpleurical nodules.
Histological exam confirmed diagnosis of sarcoidosis for the mentioned
peri-pancreatic lymph nodes
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39 % [64]. However, its frequency can be underestimated,
because bone lesions are often asymptomatic [6]; frequently,
the disease is misdiagnosed, being interpreted as metastatic
lesions [65].
The disease generally involves hands and feet, which
have been reported in several reviews as the most affected
locations [62, 64]. On conventional radiography, lesions pro-
duce a lacy pattern of osteolytic areas in the digits (Fig. 16)
[19, 66–68]; cortical erosions and pathological fractures may
be observed [19].
Large bones and axial skeleton involvement is uncommon;
however, the disease may be encountered in ribs, long bones,
skull and vertebrae. Axial skeleton disease, without pulmo-
nary lesions, is rarely reported [6].
Lesions of large bone and axial skeleton can be detected
as radiolucent (Fig. 17) or sclerotic areas (Fig. 18) [66].
Sclerotic areas are well depicted on CT images, consisting
of hyperdense homogeneous areas, round or oval in shape
(Fig. 18); osteolysis produces a hypodense appearance, and
differential diagnosis from metastatic lesions is required.




enhanced axial CT images
(Fig. 11a–c) show multiple
enlarged and confluent lymph
nodes, located in the mediastinum
(Fig. 11a), in the celiac region
(Fig. 11b), and in the mesentery
(Fig. 11c). Coronal MPR image
(Fig. 11d) clearly depicts
lymphadenopathy in the right side
of the mediastinum, in the aorto-
pulmonary recess (white arrow),
at the right paratracheal level
(empty white arrowheads), and
in the left perirenal space (white
asterisk). Spleen enlargement
can also be detected (white curved
arrow)
Fig. 12 Multiorgan sarcoidosis,
with multiple hypodense lesions
in the renal parenchyma (white
arrows in Fig. 12a–c). In the left
kidney, in the lower part of the
parenchyma, lesions have nodular
appearance. Splenomegaly can
also be observed (white
arrowheads). In the Fig. 12d, a
sarcoidosis pattern is observed on
HRCT images (white arrows).
Sarcoid lesions in the renal
parenchyma were confirmed by
biopsy
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Fig. 13 “Heerfordt’s syndrome” in a 60-year-old woman. Clinically, the
patient complained of sudden appearance of blurred vision, headache,
and mouth deviation to the left after fever. MRI shows bilateral enhance-
ment of facial nerve (white arrows on Fig. 13a), recognizable on T1-
weighted image obtained after gadolinium administration. She showed
a complete facial palsy and a bilateral enlargement of the cheeks. Physical
examination revealed an unpainful enlargement of the left parotid gland,
left facial nerve and left abducent nerve palsy. Nodular lesions were found
in the parotid glands (same patient in Fig. 8), with evident contrast
enhancement on T1-weighted acquisitions after contrast enhancement
(Fig. 13b, empty white arrowhead) and on DWI sequences (Fig. 13c,
white arrowheads). Chest CT scan and fibrobronchoscopy with broncho-
alveolar lavage were suggestive of sarcoidosis. The biopsy of the left
parotid gland depicted dense, non-caseating granulomatous infiltrate
(Fig. 13d). Lymphocytes and epithelioid histiocytes with abundant eosin-
ophilic cytoplasm and oval vesicular nuclei are observed (H&E 250X).
The clinical, radiological and histopathological patterns were consistent
with the diagnosis of Heerfordt’s syndrome
Fig. 14 Leptomeningeal
localizations of sarcoidosis.
Lesions are more visible on
enhanced T1-weighted
acquisitions, with increased
enhancement along the surface of
the brainstem (white arrows in
Fig. 14a–b). Sarcoid nodules are
also visible in the superior
cerebellar cistern (white arrows in
Fig. 14c–d)
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The MRI appearance of bone lesions is heterogeneous.
Vardahanabuhuti et al. described how lesions can appear
as bone marrow infiltration areas, Bround, cannonball-like
or intramedullary lesions^; lesions can reproduce a Bstarry
sky appearance^ [19]. Sarcoid lesions show high signal
intensity on T2-weighted images, high-density proton se-
quences and STIR acquisitions; on T1-weighted images,
lesions are generally hypointense.
In patients with sarcoidosis, skeletal FDG uptake can
be observed (Fig. 19); these increased sites of metabolic
activity are not specific. In combination with thoracic
features of sarcoidosis, bone sites of increased uptake
can be interpreted as Bskeletal sarcoidosis^ [36]. Muscle
involvement is frequently misdiagnosed, being reported
as chronic myopathy, acute myositis, or pseudotumour
[69].
Ocular sarcoidosis
Ocular involvement occurs in approximately 25–60 % of pa-
tients with systematic sarcoidosis, more frequently in the third
decade (first peak of incidence) and between the sixth and the
seventh decade (second peak of incidence) [70]. This may
represent the initial manifestation of the disease [71], or may
co-exist with asymptomatic systemic disease and can be vi-
sion-threatening.
In most cases (about 20 %), uveitis is the first common
manifestation: symptoms that patients complain of include
tearing, photophobia, pain, infection, lacrimation, redness.
However, these symptoms can be absent: Bsilent uveitis^
is very insidious because it may produce permanent ocu-
lar damage before treatment. The common type of uveitis
is often anterior in black patients, posterior in white pa-
tients, specifically in elderly female patients [72–74].
Blindness in at least one eye occurs in about 10 % of
patients and the main cause is cystoid macular oedema
[75, 76].
In the anterior segment, conjunctivitis occurs in 7–
70 % of the patients with ocular sarcoidosis and, togeth-
er with lacrimal gland involvement, is usually asymp-
tomatic. The sarcoidosis granulomas in the eyes have
the appearance of yellow Bmillet-seed^ nodules. When
the disease involves the posterior part of the eyes, it is
frequently associated with neurological manifestations:
optic nerve disease, cranial nerve palsies, encephalopa-
thy, and disorders of the hypothalamus and pituitary
gland [77, 78].
Fig. 15 MRI images show spinal
cord involvement in a 54-year-old
man. T2-weighted image
(Fig. 15a) demonstrates an
extensive area of high signal
intensity in the spinal cord (white
arrow). On enhanced T1-
weighted acquisitions, a
peripheral enhancement (white
arrows) can be depicted (Fig. 15b
and c), suggesting meningeal
involvement
Fig. 16 53 year-old man with
hand involvement. A lacy pattern
with small osteolytic areas is
recognizable in the digits (white
arrows in Fig. 16a and b)
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Other manifestations of ocular sarcoidosis include granu-
lomatous iridocyclitis, retinal periphlebitis and chorioretinis;
foci of retinal involvement are generally revealed by
fluorangiography as Bpunched-out^ lesions (Fig. 20). In 7 to
17% of cases of ocular sarcoidosis occur conjunctival follicles
[79, 80].
Cutaneous sarcoidosis
In sarcoidosis, cutaneous involvement occurs in 20–35 %
of patients [81]. The cutaneous lesions are distinguished
as Bnon-specific inflammatory type^ and Bspecific type^
[82].
Erythema nodosum is the most common nonspecific cuta-
neous lesion of sarcoidosis. In most cases it occurs with sub-
cutaneous erythematous nodules (Fig. 21a), often observed on
anterior tibia, accompanied by systemic symptoms, such as
fever, malaise or polyarthralgias [83].
The term Bspecific^ is misleading, because clinically
lesions are not specific to sarcoidosis, and the only way
to make a diagnosis is biopsy. Papule (Fig. 21b) is the
most common specific cutaneous lesion of sarcoidosis:
although the face is the main location, it may occur any-
where and may be of various colours. Larger and flat-
Fig. 17 Multiple bone lesions in
a 51 year-old man. Sagittal
multiplanar CT image (Fig. 17a)
and axial CT image (Fig. 17b)
show a lytic area involving a
dorsal vertebra (white arrows),
with increased uptake on PET-CT
scan (Fig. 17c). Histological
examination revealed the
presence of sarcoid disease of
dorsal vertebra. Sarcoid lesion is
also recognizable in the right
ischial tuberosity (white arrows of
Fig. 17d and e)
Fig. 18 49 year-old woman with
axial skeleton involvement. Axial
CT images show osteosclerotic
lesions (arrowheads) of dorsal
vertebrae (Fig. 18a), sacrum
(Fig. 18b), and bilateral iliac crest
(Fig. 18b). A lymphadenopathy
can be also observed on Fig. 18b
(white asterisk). Coronal
reconstruction clearly depicts
small osteosclerotic foci in dorsal
vertebrae. Sagittal reconstruction
(Fig. 18d) demonstrates lesions in
contiguous or non-contiguous
vertebrae in the dorsal and lumbar
spine
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topped plaques (Fig. 21c) are very frequent and can be
single or multiple; the lesions are located on the face,
trunk or extremities.
A characteristic clinical manifestation of cutaneous sar-
coidosis is lupus pernio (Fig. 21d): it appears as chronic and
indurated papules or plaques in the middle-face, particularly
the alar rim of the nose.
The diagnosis of cutaneous sarcoidosis is performed with
histological examination of a cutaneous biopsy, which shows
the presence of sarcoidal granuloma without any cornoid
lamella.
Cardiac sarcoidosis
Cardiac involvement with clinical manifestations occurs in 2–
7 % of patients, but the occult form is much more present
[84–86].
Sarcoidosis characteristic granulomatous lesion mani-
fests in any part of the heart, but the myocardium is most
frequently involved [87]. In order of frequency, the areas
most affected are the left ventricular wall, interventricular
septum, papillary muscles, right ventricula and atria [88,
89]. Valvular involvement is rare, but the impaired
Fig. 19 Skeletal sarcoidosis in a 71-year-old woman. Bilateral thoracic
hilar lymphadenopathy is shown on PET-CT (Fig. 19a, white
arrowheads). Increased sites of metabolic activity are also recognizable
in the right scapula (Fig. 19b), in the sacrum and in the iliac crest
(Fig. 19d). In presence of thoracic features of sarcoidosis, bone sites of
increased uptake can be interpreted as “skeletal sarcoidosis”
Fig. 20 A 62-year-old woman
with retinal involvement. Patient




the presence of a sarcoid nodule.
She also referred to light flashes
and blurred vision. Digital retinal
angiography scan shows
Bpunched-out^ choroidoretinal
lesions (white arrows on
Fig. 20a–d). Chest CT (Fig. 20e
and f) demonstrates mediastinal
nodal enlargement, suggesting
sarcoidosis in stage I
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functioning of the cardiac valves may occur after sarcoid
reaction of the papillary muscles [88, 90]. Pericardium
involvement may be present, rarely determining constric-
tive pericarditis [91].
Gadolinium-enhanced cardiac MRI allows us to
detect differences between normal tissue and altered tis-
sue, the latter displaying areas of focal enhancement,
particularly in the myocardial wall or subepicardial
region (Fig. 22) [92, 93]. In addition, other MRI find-
ings include mural oedema, pericardial effusion, myo-
cardial or pericardial thickening and segmental wall
motion abnormalities.
Radionuclide scans with gallium, citrate, and thallium are
used for diagnosis and follow-up in patients with cardiac sar-
coidosis [94, 95]. PET-CT is a technique for diagnosis of
active involvement of cardiac sarcoidosis and can be used
for the thoracic and extra-thoracic stage of the disease [96].
Conclusions
Abdominal, neural, musculo-skeletal, cutaneous, ocular and
cardiac sarcoidosis has extremely variable clinical features;
their imaging findings can often simulate other diseases,
Fig. 21 Pattern of skin




nodules, as well recognizable on
Fig. 21a; it represents the most
common non-specific lesions of
cutaneous disease. Papules,
clearly appreciable on Fig. 21b,
represent the most common
Bspecific^ cutaneous
manifestation of sarcoidosis: they
may occur anywhere. Multiple
large annular plaques can be a
cutaneous appearance of
sarcoidosis (Fig. 21c). Finally,
Fig. 21d shows a lupus pernio,
which represents a typical clinical
manifestation of cutaneous
sarcoidosis
Fig. 22 Cardiac MRI involvement in a patient with systemic
sarcoidosis. Triple inversion recovery (Fig. 22a) and double-
inversion recovery sequences (Fig. 22b), both obtained on short
axis views, clearly show hypointense calcified myocardial and
pericardial nodules (white arrows). After gadolinium administra-
tion, foci of delayed enhancement (white arrows), involving also
the pericardium, are recognizable (Fig. 22c)
584 Insights Imaging (2016) 7:571–587
namely malignancies. Sarcoidosis should be considered in the
differential diagnosis of multiple lesions of brain, abdomen
and bones in patients with suspected or proved disease.
In patients with pulmonary sarcoidosis, a careful evaluation
of patients’ symptoms is mandatory in order to identify other
locations of the disease. Radiologists, correlating imaging and
clinical-pathologic findings, play an important role in diagno-
sis and follow-up of the disease, in order to reduce its morbid-
ity and mortality.
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